Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
5 hedge funds and large institutions have $6.72M invested in Forward Pharma A/S American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
2% more capital invested
Capital invested by funds: $6.61M → $6.72M (+$113K)
38% less funds holding
Funds holding: 8 → 5 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$82.5K |
| 2 |
Morgan Stanley
New York
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$881K |
| 2 |
Renaissance Technologies
New York
|
-$436K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$93K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4K |
FWP Hedge Fund Activity: Q2 2021 in Review
5 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2021, worth a combined $6.72M — up 1.7% from $6.61M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FWP and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Acadian Asset Management, adding an estimated $82.5K. The largest seller was BVF Inc, cutting an estimated $881K.
- 5 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2021, down from 8 in Q1 2021.
- Funds reported $6.72M of Forward Pharma A/S American Depositary Shares stock for Q2 2021, up 1.7% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2021 and 3 closed out, a net change of -3 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2021 was Acadian Asset Management, an estimated $82.5K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2021 was BVF Inc, an estimated $881K sold.
Based on aggregated 13F filings for Q2 2021.